Showing results for IU Simon Comprehensive Cancer Center

INDIANAPOLIS — An Indiana University cancer researcher has identified eight new genomic regions that increase a person’s risk for skin cancer. Jiali Han, Ph.D., and colleagues discovered eight new loci—locations on a person’s genome—that are susceptible to the development of squamous cell skin cancer. Han is the Rachel Cecile Efroymson Professor in Cancer Research at […]

INDIANAPOLIS — A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute “Cancer Moonshot” grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia. The research promises to achieve more effective, better targeted and less toxic therapies for […]

INDIANAPOLIS — On a night when Chuck Pagano returned to Indianapolis, Colts owner Jim Irsay pledged $1 million to cancer research in his former coach’s honor, helping to raise more than $1.8 million to support scientists at the Indiana University Melvin and Bren Simon Cancer Center. Colts Chief Operating Officer Pete Ward made the announcement […]

INDIANAPOLIS—A $1.2 million Department of Defense grant has been awarded to an Indiana University School of Medicine physician whose research explores a cascade of events that decreases quality of life and treatment responses for patients with metastatic bone cancer. Theresa Guise, MD, hopes to understand the role of the tumor-bone microenvironment on glucose metabolism and […]

INDIANAPOLIS — Indiana University School of Medicine cancer researchers who have been working to lessen the debilitating side effects caused by chemotherapy have been awarded $2.3 million to continue their studies. Jill Fehrenbacher, PhD, and Mark Kelley, PhD, are recipients of the five-year grant (1R01CA231267) from the National Cancer Institute, which will enable them to […]

Indiana University School of Medicine radiology researchers will recruit 3,000 women to participate in TMIST, a nationwide study comparing the two most common technologies used for breast cancer screening. Tomosynthesis, also known as three-dimensional or 3-D mammography screening, will be compared with 2-D or conventional mammography in a study conducted by the National Cancer Institute […]